These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Comparative immunological and biochemical analyses of viruses in the Venezuelan equine encephalitis complex. Kinney RM; Trent DW; France JK J Gen Virol; 1983 Jan; 64 (Pt 1)():135-47. PubMed ID: 6822814 [TBL] [Abstract][Full Text] [Related]
50. Modification of Venezuelan equine encephalomyelitis virus infection in mice by X radiation. Hilmas DE; Whitmire RE; Dill GS Am J Vet Res; 1977 Sep; 38(9):1413-9. PubMed ID: 921037 [TBL] [Abstract][Full Text] [Related]
51. [The relationship between mosquito vectors and aquatic birds in the potential transmission of 2 arboviruses]. Adames AJ; Dutary B; Tejera H; Adames E; Galindo P Rev Med Panama; 1993 May; 18(2):106-19. PubMed ID: 8101009 [TBL] [Abstract][Full Text] [Related]
52. [Viral agents in patients with infectious processes of the central nervous system]. Valero N; Henríquez R; Hernández C; Pomeda O; Romero M; Urdaneta F; Atencio R; Larreal Y; Espina LM; Rodríguez Z Invest Clin; 2001 Dec; 42(4):255-67. PubMed ID: 11787270 [TBL] [Abstract][Full Text] [Related]
53. Radial haemolysis in gel used in serological studies on Venezuelan equine encephalomyelitis virus. Gaidamovich SY; Melnikova EE; Obukhova VR Acta Virol; 1981 Jan; 25(1):36-40. PubMed ID: 6112864 [TBL] [Abstract][Full Text] [Related]
54. Endemic Venezuelan equine encephalitis in northern Peru. Aguilar PV; Greene IP; Coffey LL; Medina G; Moncayo AC; Anishchenko M; Ludwig GV; Turell MJ; O'Guinn ML; Lee J; Tesh RB; Watts DM; Russell KL; Hice C; Yanoviak S; Morrison AC; Klein TA; Dohm DJ; Guzman H; Travassos da Rosa AP; Guevara C; Kochel T; Olson J; Cabezas C; Weaver SC Emerg Infect Dis; 2004 May; 10(5):880-8. PubMed ID: 15200823 [TBL] [Abstract][Full Text] [Related]
55. [Laminin-binding protein (LBP) as a cellular receptor for the virus of Venezuelan equine encephalomyelitis (VEE): Part 1. A study of the interaction between VEE virus virions and the human recombinant LBP]. Bondarenko EI; Protopopova EV; Konovalova SN; Sorokin AV; Kachko AV; Surovtsev IV; Loktev VB Mol Gen Mikrobiol Virusol; 2003; (4):36-9. PubMed ID: 14664162 [TBL] [Abstract][Full Text] [Related]
56. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186 [TBL] [Abstract][Full Text] [Related]
57. Complete sequence of Venezuelan equine encephalitis virus subtype IE reveals conserved and hypervariable domains within the C terminus of nsP3. Oberste MS; Parker MD; Smith JF Virology; 1996 May; 219(1):314-20. PubMed ID: 8623548 [TBL] [Abstract][Full Text] [Related]
58. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. Elvin SJ; Bennett AM; Phillpotts RJ J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032 [TBL] [Abstract][Full Text] [Related]
59. Identification and genetic analysis of Panama-genotype Venezuelan equine encephalitis virus subtype ID in Peru. Oberste MS; Weaver SC; Watts DM; Smith JF Am J Trop Med Hyg; 1998 Jan; 58(1):41-6. PubMed ID: 9452290 [TBL] [Abstract][Full Text] [Related]
60. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Rosas CT; Paessler S; Ni H; Osterrieder N Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]